Sucralfate

A potent competitive inhibitor of both Src and Lck (IC₅₀ = 44 and 88 nM, respectively), as well as Csk and Yes also inhibits RIP-2.

A cell-permeable, selective inhibitor of calcineurin-mediated dephosphorylation of NFAT that does not disrupt other calcineurin-dependent pathways disrupts NFAT-dependent expression of IL-2 and TNF-&alpha when transfected in Jurak T cells and

A potent competitive inhibitor of both Src and Lck (IC₅₀ = 44 and 88 nM, respectively), as well as Csk and Yes also inhibits RIP-2.

A cell-permeable, selective inhibitor of calcineurin-mediated dephosphorylation of NFAT that does not disrupt other calcineurin-dependent pathways disrupts NFAT-dependent expression of IL-2 and TNF-&alpha when transfected in Jurak T cells and

A broad spectrum antibiotic that alters translation by prokaryotic ribosomes, resulting in bacterial cell death used as a selective agent to isolate transformants that are expressing a kanamycin resistance gene, usually neomycin phosphotransferase

A potent competitive inhibitor of both Src and Lck (IC₅₀ = 44 and 88 nM, respectively), as well as Csk and Yes also inhibits RIP-2.

A broad spectrum antibiotic that alters translation by prokaryotic ribosomes, resulting in bacterial cell death used as a selective agent to isolate transformants that are expressing a kanamycin resistance gene, usually neomycin phosphotransferase

A potent competitive inhibitor of both Src and Lck (IC₅₀ = 44 and 88 nM, respectively), as well as Csk and Yes also inhibits RIP-2.

Anti-SLC2A11 solute carrier family 2 (facilitated glucose tr

Anti-GIP gastric inhibitory polypeptide, 100ul UN 1687 6.1 P

Anti-SRCIN1 SRC kinase signaling inhibitor 1, 100ul UN 1687

Anti-SUGP2 SURP and G patch domain containing 2, 100ul UN 16